Just physically squeezing cells or bathing them in acidic conditions can readily reprogram them into an embryonic state
In 2006, Japanese researchers reported a technique for creating cells that have the embryonic ability to turn into almost any cell type in the mammalian body — the now-famous induced pluripotent stem (iPS) cells. In papers published this week in Nature, another Japanese team says that it has come up with a surprisingly simple method — exposure to stress, including a low pH — that can make cells that are even more malleable than iPS cells, and do it faster and more efficiently.
“It’s amazing. I would have never thought external stress could have this effect,” says Yoshiki Sasai, a stem-cell researcher at the RIKEN Center for Developmental Biology in Kobe, Japan, and a co-author of the latest studies. It took Haruko Obokata, a young stem-cell biologist at the same centre, five years to develop the method and persuade Sasai and others that it works. “Everyone said it was an artefact — there were some really hard days,” says Obokata.
Obokata says that the idea that stressing cells might make them pluripotent came to her when she was culturing cells and noticed that some, after being squeezed through a capillary tube, would shrink to a size similar to that of stem cells. She decided to try applying different kinds of stress, including heat, starvation and a high-calcium environment. Three stressors — a bacterial toxin that perforates the cell membrane, exposure to low pH and physical squeezing — were each able to coax the cells to show markers of pluripotency.
But to earn the name pluripotent, the cells had to show that they could turn into all cell types — demonstrated by injecting fluorescently tagged cells into a mouse embryo. If the introduced cells are pluripotent, the glowing cells show up in every tissue of the resultant mouse. This test proved tricky and required a change in strategy. Hundreds of mice made with help from mouse-cloning pioneer Teruhiko Wakayama at the University of Yamanashi, Japan, were only faintly fluorescent. Wakayama, who had initially thought that the project would probably be a “huge effort in vain”, suggested stressing fully differentiated cells from newborn mice instead of those from adult mice. This worked to produce a fully green mouse embryo.
Still, the whole idea was radical, and Obokata’s hope that glowing mice would be enough to win acceptance was optimistic. Her manuscript was rejected multiple times, she says.
To convince sceptics, Obokata had to prove that the pluripotent cells were converted mature cells and not pre-existing pluripotent cells. So she made pluripotent cells by stressing T cells, a type of white blood cell whose maturity is clear from a rearrangement that its genes undergo during development. She also caught the conversion of T cells to pluripotent cells on video. Obokata called the phenomenon stimulus-triggered acquisition of pluripotency (STAP).
The results could fuel a long-running debate. For years, various groups of scientists have reported finding pluripotent cells in the mammalian body, such as the multipotent adult progenitor cells described by Catherine Verfaillie, a molecular biologist then at the University of Minnesota in Minneapolis. But others have had difficulty reproducing such findings. Obokata started the current project in the laboratory of tissue engineer Charles Vacanti at Harvard University in Cambridge, Massachusetts, by looking at cells that Vacanti’s group thought to be pluripotent cells isolated from the body. But her results suggested a different explanation: that pluripotent cells are created when the body’s cells endure physical stress. “The generation of these cells is essentially Mother Nature’s way of responding to injury,” says Vacanti, a co-author of the latest papers.
One of the most surprising findings is that the STAP cells can also form placental tissue, something that neither iPS cells nor embryonic stem cells can do. That could make cloning dramatically easier, says Wakayama.
The Latest on: New Way to Make Stem Cells
via Google News
The Latest on: New Way to Make Stem Cells
- Scientists generate millions of naïve human pluripotent stem cells, far more than have ever been producedon May 13, 2020 at 11:17 am
A UB team has developed a method that dramatically ramps up production of mature human cells in mouse embryos.
- Millions Of Human Stem Cells Successfully Develop Within Mouse Embryo Hoston May 13, 2020 at 11:00 am
Scientists have successfully generated millions of mature human cells in a mouse embryo, paving the preliminary road for future stem cell treatments capabl ...
- One year on, Capricor's stem cell therapy appears to help DMD patients in small study, but investors balk at the dataon May 13, 2020 at 7:41 am
Repeated setbacks aside, little Capricor has suggested it has generated some long-term data to support its pursuit to garner approval for its stem cell therapy for Duchenne muscular dystrophy, ...
- Revealed: two men in China were first to receive pioneering stem-cell treatment for heart-diseaseon May 13, 2020 at 6:07 am
The two men are reportedly doing well one year on, but there is no way to confirm that the unpublished treatment using ‘reprogrammed’ stem cells works.
- 5 Stem Cell Companies Racing Towards COVID-19 ARDS Therapyon May 7, 2020 at 10:35 am
Athersys and Mesoblast enroll first patients in Phase II/III placebo controlled COVID-19 ARDS trials. Capricor, Mesoblast and Pluristem make waves with very pro ...
- The Role of Microphysiological Systems for Oncology and Stem Cell Researchon May 6, 2020 at 4:22 am
In this interview, Dr. Nancy Allbritton from The Allbritton Lab talks to News-Medical and Life Sciences about the revolutionary technology and techniques for the application of new technologies for ...
- Clinical Trials Of Mesoblast’s Stem Cell Treatment For COVID-19 Set To Begin Soonon May 2, 2020 at 12:14 am
Melbourne-based biotech company Mesoblast will enroll up to 300 COVID-19 patients for a randomized, controlled study of its stem cell therapy.
- A step toward a better way to make gene therapies to attack cancer, genetic disorderson April 28, 2020 at 12:24 am
A UCLA-led research team today reports that it has developed a new method for delivering DNA into stem cells and immune cells safely, rapidly and economically. The method, described in the journal ...
- Reversing diabetes with CRISPR and patient-derived stem cellson April 22, 2020 at 12:36 pm
Insulin injections can control diabetes, but patients still experience serious complications such as kidney disease and skin infections. Transplanting pancreatic tissues containing functional ...
- CRISPR combines with stem cell therapy to reverse diabetes in miceon April 21, 2020 at 5:00 pm
For a few years now, scientists at Washington University have been working on techniques to turn stem cells into pancreatic beta cells as a way of addressing ... in search of new and improved ...
via Bing News